This combination is used for long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD). Salmeterol is a long-acting ?2-agonist that provides sustained bronchodilation, while Fluticasone Propionate reduces airway inflammation, edema, and mucus secretion. Together, they help maintain open airways, improve lung function, and prevent disease exacerbations.